Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
View Patent ↗The present invention provides synthetic 5′UTRs comprising a first polynucleotide fragment and a second polynucleotide fragment, wherein the first polynucleotide fragment comprises at least one splice site of a first eukaryotic gene, the second polynucleotide fragment comprises at least a portion of 5′ untranslated region of a second eukaryotic gene, and the first polynucleotide fragment is located 5′ of the second polynucleotide fragment. In one embodiment, the first polynucleotide fragment comprises the second intron of a sarcoplasmic/endoplasmic reticulum calcium ATPase gene and the second polynucleotide fragment comprises at least a portion of the 5′ untranslated region (5′UTR) of a eukaryotic casein gene. The synthetic 5′UTRs are useful for increasing the expression of a transgene when positioned between a promoter and a transgene within an expression vector. The present invention also provides vectors comprising synthetic 5′UTRs and methods for increasing the expression of a transgene using synthetic 5′UTRs.
1. A polynucleotide construct comprising: a first polynucleotide comprising one of SEQ ID NOS:2 and 4-6, a second polynucleotide comprising one of SEQ ID NOS:3 and 8-10, a third polynucleotide encoding a sequence of interest to be expressed in a cell, wherein the first polynucleotide is located 5′ of the second polynucleotide.
2. The polynucleotide construct of claim 1 , wherein the polynucleotide construct lacks restriction sites for the following restriction endonucleases: AsiS I, Pac I, SbfI, Fse I, Asc I, MIu I, SnaB I, Not I, Sal I, Swa I, Rsr II, BsiW I, Mfe I, Nhe I, Nsi I, CIa I, Nde I, Nsi I, Kpn I, Nco I and Pst I.
3. The polynucleotide construct of claim 1 , wherein the polynucleotide construct includes restriction sites at the 5′ and 3′ ends to facilitate cloning into a vector.
4. The polynucleotide construct of claim 3 , wherein the polynucleotide includes a restriction site for MIu I at the 5′ end and a restriction site for Mfe I at the 3′ end.
5. A vector comprising the polynucleotide construct of claim 1 .
6. A synthetic gene construct comprising the polynucleotide construct of claim 1 .
7. A host cell comprising the polynucleotide construct of claim 1 .
8. A kit comprising the polynucleotide construct of claim 1 .
9. An expression vector comprising a promoter and the polynucleotide construct of claim 1 , wherein the polynucleotide construct is operably linked to the promoter, and
positioned between a promoter and the sequence of interest to be expressed, wherein the first polynucleotide is positioned toward the promoter, and
wherein the second third polynucleotide is positioned 3′ of the second polynucleotide.
10. A method for expressing the sequence of interest in a host cell, the method comprising:
(a) transfecting a host cell with the expression vector of claim 9 ; and
(b) culturing said host cell under conditions suitable to obtain expression of said sequence of interest.
11. The polynucleotide construct of claim 1 , wherein the first polynucleotide comprises SEQ ID NO:2 and the second polynucleotide comprises SEQ ID NO:3.
12. The polynucleotide construct of claim 1 , wherein the first polynucleotide comprises SEQ ID NO:4 and the second polynucleotide comprises SEQ ID NO:3.
13. The polynucleotide construct of claim 1 , wherein the polynucleotide construct comprises SEQ ID NO:1 or SEQ ID NO:7.